US Stem Cell Inc (USRM)

[Archery Class]

Not pursuing the back and forth of RMAT approval with the FDA. Deciding to shift focus to increase revenue. Apparently they were constantly needing to provide more information which was 'straining them financially'.

Most read this as either RMAT denial, or the company just giving up altogether on working with the FDA for the moment.

Since many were here on the 'inevitable expectation that RMAT would be approved' - those folks jumped ship as soon as they could, albeit with grave losses. Instead of walking down, panic selling has been in serious effect.

So, if you bet short - today has been good to you. If you're a long, you might be biting your nails holding and hoping this is just a short term issue. Some are also content with sitting on whatever shares they have regardless of what happens over the next several months.

Today is a great day to have spare cash in the account